Palak J. Trivedi
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
Letter: Therapeutic Targeting of PPARs in PBC-Additional Considerations. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: May 22, 2026
Interpreting surgical associations in primary sclerosing cholangitis: Caution in clinical messaging.
Interpreting surgical associations in primary sclerosing cholangitis: Caution in clinical messaging.
Journal: Hepatology (Baltimore, Md.)
Published: March 12, 2026
Can we cure primary biliary cholangitis?
Journal: Current opinion in immunology
Published: March 05, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.
Journal: Nature reviews. Gastroenterology & hepatology
Published: February 19, 2026
Conserved Ductular Reaction Mechanisms in Biliary Atresia and Primary Sclerosing Cholangitis Derived From Single-Cell and Spatial Transcriptomics.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 05, 2025
Conserved ductular reaction mechanisms in biliary atresia and PSC derived from single-cell and spatial transcriptomics.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 05, 2025
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: November 05, 2025
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: October 21, 2025
6-Mercaptopurine vs Mycophenolate Mofetil in Autoimmune Hepatitis and Azathioprine Intolerance: A Multicenter Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 03, 2025
Last Updated: 09/26/2026